In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 33 for your search:
Cancer Type/Condition:  Adrenocortical carcinoma
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CSOM230B2412, NCT01794793

2.

Phase: Phase III, Phase II
Type: Diagnostic
Status: Approved-not yet active
Age: 30 and over
Sponsor: Other
Protocol IDs: KS8-341, 2012-003604-13, NCT02010957

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: EudraCT 2007-007262-38, NCT00777244

4.

Phase: Phase III
Type: Screening
Status: Active
Age: 5 to 71
Sponsor: Other
Protocol IDs: CSET2011/1748, NCT01464086

5.

Phase: Phase III
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011/1810, NCT01504555

6.

Phase: Phase III
Type: Educational/Counseling/Training, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: UHN REB 09-0855-C, CIHR, NCT01506492

7.

Phase: Phase II, Phase I
Type: Tissue collection/Repository
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 93-102, NCT00579163

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TKM-PLK1-001, NCT01262235

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BBI608-201, NCT01325441

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130046, 13-C-0046, NCT01766635

11.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 76,770, NCT00252174

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EudraCT 2008-000759-91, NCT00786110

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months and over
Sponsor: Other
Protocol IDs: CDR0000066485, BC-AD-2, NCT00003453

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 16 and over
Sponsor: Other
Protocol IDs: I206, NCT01396408

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 11/106, U1111-1132-5574, NCT01676428

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 130114, 13-C-0114, NCT01833832

17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and over
Sponsor: Other
Protocol IDs: 09-090, NCT01099644

18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ATR-101-001, NCT01898715

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 3 to 70
Sponsor: NICHD
Protocol IDs: 000160, 00-CH-0160, NCT00005927

20.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: Wue-ACC-R-86-03, NCT00453674

21.

Phase: No phase specified
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: Wue-ACC-Mitotane, NCT00568139

22.

Phase: No phase specified
Type: Diagnostic, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: Wue-Adrenal-Tumors-92/2002, NCT00669266

23.

Phase: No phase specified
Type: Tissue collection/Repository
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: IPACTR, NCT00700414

24.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 to 90
Sponsor: Other
Protocol IDs: retroper adrenal, NCT00894335

25.

Phase: No phase specified
Type: Biomarker/Laboratory analysis
Status: Active
Age: 7 and over
Sponsor: NCI
Protocol IDs: 090242, 09-C-0242, NCT01005654
1   
New Search